Pfizer Inc. Chief Executive Officer Albert Bourla cashed out 62 per cent of his stock in the company on the same day it announced the success of its experimental COVID-19 vaccine, a regulatory filing showed.
Bourla on Monday sold 132,508 of his shares at an average price of US$41.94 — a total of US$5.6 million — not far off the 52-week high of US$41.99 Pfizer at which the stock traded.
Full story - https://nationalpost.com/news/world...-of-shares-same-day-vaccine-announcement-made
Talk of Making hay while the sun shines......
Bourla on Monday sold 132,508 of his shares at an average price of US$41.94 — a total of US$5.6 million — not far off the 52-week high of US$41.99 Pfizer at which the stock traded.
Full story - https://nationalpost.com/news/world...-of-shares-same-day-vaccine-announcement-made
Talk of Making hay while the sun shines......





